IL1B and Lysosomal disease: Although we did not test many other combinations, the likelihood is that whether a substrate is primary or secondary is irrelevant for stimulation of NLRP3 inflammasome activation, suggesting that NLRP3 and IL‐1 secretion will have an impact in most neuronopathic lysosomal diseases.